Skip to main content
Top
Published in: PharmacoEconomics 2/2004

01-02-2004 | Current Opinion

The Generation Gap

Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions

Authors: Ron Keren, Susmita Pati, Chris Feudtner

Published in: PharmacoEconomics | Issue 2/2004

Login to get access

Abstract

Differences between children and adults have both technical and ethical implications for the design, interpretation and employment of economic analyses of health-related programmes. Even though policy makers increasingly turn to economic analyses to inform decisions about resource allocation, pertinent child-adult differences have received fragmented discussion in leading methodological references.
Key areas warranting attention include: the ways in which a child’s distinctive biology modifies the cost and effectiveness of healthcare interventions; challenges in assessing utilities for infants and young children given their limited but developing cognitive capacity; how a child’s age, dependency and disability affect the selection of the appropriate time horizon and scope of the analysis; whether a child’s non-wage earning productivity should be incorporated into analyses, and if so, what metric to use; what principles of equity policy makers should employ in using economic evaluations to choose between child- and adult-focused interventions; and whether special protective measures should be introduced to secure the rights and interests of children who cannot advocate for themselves.
Literature
1.
go back to reference Halpern SA. American pediatrics: the social dynamics of professionalism, 1880–1980. Berkeley (CA): University California Press, 1988 Halpern SA. American pediatrics: the social dynamics of professionalism, 1880–1980. Berkeley (CA): University California Press, 1988
2.
go back to reference Stern AM, Markel H. Formative years: children’s health in the United States: 1880–2000. Ann Arbor (MI): University of Michigan Press, 2002CrossRef Stern AM, Markel H. Formative years: children’s health in the United States: 1880–2000. Ann Arbor (MI): University of Michigan Press, 2002CrossRef
3.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
4.
go back to reference Graham JD, Goldie SJ, Segui-Gomez M, et al. Reducing risks to children in vehicles with passenger airbags. Pediatrics 1998; 102: e3 Graham JD, Goldie SJ, Segui-Gomez M, et al. Reducing risks to children in vehicles with passenger airbags. Pediatrics 1998; 102: e3
5.
go back to reference Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA 1997; 278: 1418–25CrossRef Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA 1997; 278: 1418–25CrossRef
6.
go back to reference Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [comment]. New Engl J Med 1992; 327: 1832–5CrossRef Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [comment]. New Engl J Med 1992; 327: 1832–5CrossRef
7.
go back to reference Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [comment]. JAMA 1989; 262: 2847–52CrossRef Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [comment]. JAMA 1989; 262: 2847–52CrossRef
8.
go back to reference Wald DS, Law M, Moms JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202CrossRef Wald DS, Law M, Moms JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202CrossRef
9.
go back to reference Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995; 85: 667–76CrossRef Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995; 85: 667–76CrossRef
10.
go back to reference Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child 1997; 77: 347–50CrossRef Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child 1997; 77: 347–50CrossRef
11.
go back to reference Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Fur Respir l 1997; 10: 2285–94CrossRef Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Fur Respir l 1997; 10: 2285–94CrossRef
12.
go back to reference Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8CrossRef Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8CrossRef
13.
go back to reference Yi MS, Britto MT, Wilmott RW, et al. Health values of adolescents with cystic fibrosis. J Pediatr 2003; 142: 133–40CrossRef Yi MS, Britto MT, Wilmott RW, et al. Health values of adolescents with cystic fibrosis. J Pediatr 2003; 142: 133–40CrossRef
14.
go back to reference Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999; 281: 1991–7CrossRef Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999; 281: 1991–7CrossRef
15.
go back to reference Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 503–20CrossRef Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 503–20CrossRef
16.
go back to reference Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 490–502CrossRef Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 490–502CrossRef
17.
go back to reference EuroQol: a new facility for the measurement of health-related quality of life: The EuroQol Group. Health Policy 1990; 16: 199–208CrossRef EuroQol: a new facility for the measurement of health-related quality of life: The EuroQol Group. Health Policy 1990; 16: 199–208CrossRef
18.
go back to reference Stolk EA, Busschbach JJ, Vogels T. Performance of the EuroQol in children with imperforate anus. Qual Life Res 2000; 9: 29–38CrossRef Stolk EA, Busschbach JJ, Vogels T. Performance of the EuroQol in children with imperforate anus. Qual Life Res 2000; 9: 29–38CrossRef
19.
20.
go back to reference Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375–81CrossRef Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375–81CrossRef
21.
go back to reference Keren R, Helfand M, Homer C, et al. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002; 110: 855–64CrossRef Keren R, Helfand M, Homer C, et al. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002; 110: 855–64CrossRef
22.
go back to reference Barringer D, Mauk G. Survey of parents perceptions regarding hospital-based newborn hearing screening. Audiology Today 1997; 9: 18–9 Barringer D, Mauk G. Survey of parents perceptions regarding hospital-based newborn hearing screening. Audiology Today 1997; 9: 18–9
23.
go back to reference Clemens CJ, Davis SA, Bailey AR. The false-positive in universal newborn hearing screening. Pediatrics 2000; 106: E7CrossRef Clemens CJ, Davis SA, Bailey AR. The false-positive in universal newborn hearing screening. Pediatrics 2000; 106: E7CrossRef
24.
go back to reference Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8CrossRef Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8CrossRef
25.
go back to reference Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, ran domized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92 Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, ran domized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92
26.
go back to reference Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373–80PubMed Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373–80PubMed
27.
go back to reference de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54CrossRef de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54CrossRef
28.
29.
go back to reference Singer P, McKie J, Kuhse H, et al. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995; 21: 144–50CrossRef Singer P, McKie J, Kuhse H, et al. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995; 21: 144–50CrossRef
30.
go back to reference Cretin S. Cost/benefit analysis of treatment and prevention of myocardial infarction. Health Serv Res 1977; 12: 174–89PubMedPubMedCentral Cretin S. Cost/benefit analysis of treatment and prevention of myocardial infarction. Health Serv Res 1977; 12: 174–89PubMedPubMedCentral
31.
go back to reference Boyle MIL Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med 1983; 308: 1330–7CrossRef Boyle MIL Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med 1983; 308: 1330–7CrossRef
32.
go back to reference Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32CrossRef Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32CrossRef
33.
go back to reference Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resources allocation. New York: Oxford University Press, 1993 Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resources allocation. New York: Oxford University Press, 1993
34.
go back to reference Proctor BD, Dalaker J. Poverty in the United States: 2001: current population reports. Washington, DC: Census Bureau, 2002: P60–219 Proctor BD, Dalaker J. Poverty in the United States: 2001: current population reports. Washington, DC: Census Bureau, 2002: P60–219
35.
go back to reference Benjamin AE, Newacheck PW, Wolfe H. Intergenerational equity and public spending. Pediatrics 1991; 88: 75–83PubMed Benjamin AE, Newacheck PW, Wolfe H. Intergenerational equity and public spending. Pediatrics 1991; 88: 75–83PubMed
36.
go back to reference Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147–54CrossRef Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147–54CrossRef
37.
go back to reference Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996; 334: 1174–7CrossRef Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996; 334: 1174–7CrossRef
38.
go back to reference Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation all or nothing’? Med Care 2000; 38: 366–73CrossRef Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation all or nothing’? Med Care 2000; 38: 366–73CrossRef
39.
go back to reference Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making 2001; 21: 180–9CrossRef Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making 2001; 21: 180–9CrossRef
Metadata
Title
The Generation Gap
Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions
Authors
Ron Keren
Susmita Pati
Chris Feudtner
Publication date
01-02-2004
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 2/2004
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200422020-00001

Other articles of this Issue 2/2004

PharmacoEconomics 2/2004 Go to the issue

Original Research Article

Cost of Stress Urinary Incontinence

Adis Pharmacoeconomic Drug Evaluation

Infliximab